A federal judge triples the $70 million awarded to Stryker Corp. after a jury ruled that Zimmer willfully infringed its patents covering wound debridement devices.
Zimmer (NYSE:ZMH) is on the hook for more than $210 million in damages owed to rival Stryker (NYSE:SYK), after a federal judge in Michigan tripled a jury’s $70 million decision.
Kalamazoo, Mich.-based Stryker sued orthopedics rival Zimmer in December 2010, alleging infringement of 3 patents covering wound debridement technology with Zimmer’s Pulsavac Plus device.
Last February a jury in the U.S. District Court for Western Michigan awarded $70 million to Stryker in damages plus royalties, ruling that Zimmer infringed all 3 patents claimed in the suit.